ArticleFrontiers in medicine2026

Treatment and clinical outcomes among stage II-IVA nasopharyngeal carcinoma patients with undetectable pretreatment Epstein-Barr viral DNA.

Ci-Ming Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.